Disruption of this integrated network (e.g., via ferroptosis inhibitors targeting ACSL4/GPX4, anti-inflammatory agents blocking HMGB1/IL-33, or HIF modulators balancing hypoxia adaptation) can break the pathogenic cycle, highlighting the therapeutic potential of targeting the networks central nodes rather than individual pathways
Potential risks include inadequate disease management, unpredictable side effects and interactions with other medications. Dont be fooled by social media Its easy to get caught up in what youre seeing and hearing online, but if it seems too good to be true it probably is
Reported complications include severe bruising, infections, abscesses and tissue necrosis
Patients Educating Patients Below is our media library for PEP Talk our virtual patient educational webinar series recorded live on the second Tuesday of every month, and our Mini PEP Talk webinar series, which are shorter, pre-recorded sessions